OralDosed ingredient Cosmetic cross-reference

Magnesium Hydroxide

CAS 1309-42-8

Magnesium Hydroxide (CAS 1309-42-8) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 4,173 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
4,173
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Magnesium Hydroxide
CAS Number
1309-42-8
UNII
NBZ3QY004S
InChIKey
VTHJTEIRLNZDEV-UHFFFAOYSA-L
ChEMBL ID
CHEMBL1200718
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientoral
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1200718 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 80 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Sedation complication 382 848.553 10079741
Creatinine renal clearance decreased 383 776.229 10011372
Infusion related reaction 1169 698.489 10051792
Cognitive disorder 579 648.475 10057668
Blood calcium decreased 411 637.821 10005395
Blood pressure fluctuation 596 629.56 10005746
Sedation 485 603.595 10039897
Orthostatic hypotension 487 598.348 10031127
Blood pressure increased 949 554.219 10005750
Blood pressure systolic increased 531 530.616 10005760
Balance disorder 607 517.511 10049848
Oxygen saturation decreased 681 513.177 10033318
Blood pressure diastolic abnormal 336 499.284 10005736
Rheumatoid arthritis 964 492.05 10039073
Toxicity to various agents 1193 458.369 10070863
Heart rate decreased 493 452.466 10019301
Blood pressure systolic abnormal 270 378.535 10005757
Hypotension 1156 374.204 10021097
Depressed level of consciousness 447 335.96 10012373
Blood pressure diastolic decreased 265 291.423 10005737
Mobility decreased 482 243.867 10048334
Throat irritation 262 227.465 10043521
Heart rate increased 432 201.271 10019303
Pain 1500 173.655 10033371
Fall 1026 170.277 10016173
Arthralgia 1247 165.777 10003239
Drug abuse 421 154.221 10013654
Nasopharyngitis 666 151.68 10028810
Macular degeneration 156 146.058 10025409
Electric shock 58 144.137 10014357
Weight increased 705 142.293 10047899
Body temperature decreased 173 133.127 10005910
Constipation 675 131.141 10010774
Respiratory rate increased 133 116.302 10038712
Temperature regulation disorder 76 111.034 10061376
Immunodeficiency 131 110.408 10061598
Condition aggravated 270 102.62 10010264
Cataract 236 100.487 10007739
Glossodynia 31 100.384 10018388
Maternal exposure during pregnancy 49 98.881 10071408
Drug interaction 174 97.646 10013710
Tooth disorder 147 92.119 10044034
Intervertebral discitis 61 90.711 10060738
Weight decreased 734 90.365 10047895
Acute kidney injury 258 88.774 10069339
Product dose omission issue 116 88.308 10084406
Food allergy 82 83.819 10016946
Post-traumatic stress disorder 63 82.334 10036316
Systemic lupus erythematosus 60 80.151 10042945
Blood pressure diastolic increased 94 79.379 10005739

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
magnesium hydroxide 6581 SU MTHSPL
MAGNESIUM HYDROXIDE 6581 SU MTHSPL
Magnesium Hydroxide 6581 SU MTHSPL
magnesium hydroxide 6581 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Magnesium Hydroxide used for in pharmaceutical contexts?

Magnesium Hydroxide (CAS 1309-42-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Magnesium Hydroxide?

Magnesium Hydroxide has 4,173 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Sedation complication, Creatinine renal clearance decreased, Infusion related reaction, Cognitive disorder, Blood calcium decreased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Magnesium Hydroxide also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Magnesium Hydroxide with EU status "restricted".

What clinical phase is Magnesium Hydroxide in?

Magnesium Hydroxide is rendered with ChEMBL max phase 4 (approved).